期刊
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY
卷 13, 期 1, 页码 1-14出版社
GALENOS YAYINCILIK
DOI: 10.4274/jcrpe.galenos.2020.2019.0190
关键词
Constipation; developmental delay; growth failure; central hypothyroidism; autism spectrum disorder; LT4; impaired sensitivity to thyroid hormone
Resistance to thyroid hormone alpha is caused by pathogenic variants in the THRA gene, with diverse clinical and laboratory features. Symptoms are similar to primary hypothyroidism, but with normal thyroid-stimulating hormone levels. Treatment with L-thyroxine can improve some clinical findings.
Resistance to thyroid hormone alpha occurs due to pathogenic, heterozygous variants in THRA. The entity was first described in 2012 and to date only a small number of patients with varying severity have been reported. In this review, we summarize and interpret the heterogeneous clinical and laboratory features of all published cases, including ours. Many symptoms and findings are similar to those seen in primary hypothyroidism. However, thyroid-stimulating hormone levels are normal. Free triiodothyronine (T3) levels are in the upper half of normal range or frankly high and free thyroxine (T4) levels are low or in the lower half of normal range. Alterations in free T3 and free T4 may not be remarkable, particularly in adults, possibly contributing to underdiagnosis. In such patients, low reverse T3 levels, normo- or macrocytic anemia or, particularly in children, mildly elevated creatine kinase levels would warrant THRA sequencing. Treatment with L-thyroxine results in improvement of some clinical findings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据